产品编号 :
Cas No. :
CAS No. |
849776-05-2 |
|---|---|
中文名称 |
(R)-4-[1-(甲基磺酰胺基)-1-氧代丙-2-基]苯基三氟甲磺酸酯 |
英文名称 |
(R)-4-(1-(Methylsulfonamido)-1-oxopropan-2-yl)phenyl trifluoromethanesulfonate |
别名 |
Ladarixin | Q27276351 | CHEMBL189475 | 849776-05-2 (free) | CS-12792 | DEH7Q6472O | AC6925 | LADARIXIN [WHO-DD] | A857904 | Ladarixin [INN] | (R)-(-)-N-(2-(4-(TRIFLUOROMETHANESULFONYLOXY)PHENYL)PROPIONYL)METHANESULFONAMIDE | DDLPYOCJHQSVSZ-SSDOTTSWSA-N | |
标准英文名 |
(R)-4-(1-(methylsulfonamido)-1-oxopropan-2-yl)phenyl trifluoromethanesulfonate |
MDL No. |
MFCD28502169 |
分子式 |
C11H12F3NO6S2 |
分子量 |
375.35 |
精确分子量 |
375.01 |
SMILES |
C[C@@H](C(NS(=O)(C)=O)=O)C1=CC=C(C=C1)OS(=O)(C(F)(F)F)=O |
标准SMILES |
CS(=O)(=O)NC(=O)[C@H](C)C1C=CC(=CC=1)OS(=O)(=O)C(F)(F)F |
用途 |
Ladarixin is an orally active, non-competitive allosteric inhibitor of CXCR1 and CXCR2; it is used in the research of COPD and asthma. |
InChIKey |
DDLPYOCJHQSVSZ-SSDOTTSWSA-N |
|
|
评论 |
|---|